NCT05696002 is a clinical trial in Rectal Cancer, sponsored by Glasgow Royal Infirmary.

Who is sponsoring NCT05696002?

NCT05696002 is sponsored by Glasgow Royal Infirmary.

What condition does NCT05696002 study?

NCT05696002 studies Rectal Cancer, Pelvic Cancer, Gynecologic Cancer, Colon Cancer.

Is NCT05696002 still recruiting?

NCT05696002 is currently recruiting now. Last updated 25 January 2023.

Last reviewed 2023-01-25 · How we verify

NCT05696002

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Advanced Pelvic Surgical Oncology Database - Prospective Observational Study

Recruiting now Last updated 25 January 2023

What this trial tests

trial in Rectal Cancer in 300 participants. Currently enrolling.

Timeline

14 January 2023

Primary endpoint
1 January 2028

1 January 2030

Quick facts

Lead sponsor	Glasgow Royal Infirmary
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	300
Start date	14 January 2023
Primary completion	1 January 2028
Estimated completion	1 January 2030
Sites	1 location across United Kingdom

Conditions studied

Rectal Cancer — all drugs for Rectal Cancer →
Pelvic Cancer — all drugs for Pelvic Cancer →
Gynecologic Cancer — all drugs for Gynecologic Cancer →
Colon Cancer — all drugs for Colon Cancer →

Sponsor

Glasgow Royal Infirmary — full company profile →

Who can join

Eligibility, any sex, with Rectal Cancer or Pelvic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective and prospective observational study of patients undergoing advanced pelvic oncological resection for maligancy including multi visceral resection, beyond TME resection and sacrectomy/flap reconstruction/urinary reconstruction at Glasgow Royal Infirmary. Goal is to study and report outcomes for patients to characterise and understand major complications, natural history of resectional patients and identify areas for future interventional study.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of differing flap reconstruction strategies in perineal closure following advanced pelvic oncological resection: a retrospective cohort study.
Galbraith NJ, McCollum C, Di Mascio L, Lowrie J, et al · · 2023 · cited 4× · PMID 37678294 · DOI 10.1097/js9.0000000000000617
Resecting Beyond the Central Pelvic Compartment in Pelvic Exenterations for Gynaecological Malignancies: Outcomes From a Tertiary Unit.
Kong CY, Galbraith NJ, McCormick A, Haddock A, et al · · 2026 · PMID 41410155 · DOI 10.1111/ajo.70079

Verify or expand the search:

Other recruiting trials for Rectal Cancer

Currently open trials in the same condition.

NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT07537998 — Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a · Phase 2, PHASE3 · recruiting
NCT07501845 — Registry Maastro Applicator · recruiting
NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres · NA · recruiting
NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting

Other Glasgow Royal Infirmary trials

Trials by the same sponsor.

NCT04484545 — Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection · unknown
NCT04029246 — Re-engaging Patients With Hepatitis C Into Care · NA · unknown
NCT03554668 — Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study) · completed
NCT03466528 — Alcohol: Thiamine and or Magnesium 1 · Phase 2, PHASE3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05696002 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Glasgow Royal Infirmary
Last refreshed: 25 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05696002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing